$ILMN

Meister Keith A. sold $11.4M of ILMN (indirect holdings)

Meister Keith A. sold 70,262 indirectly-held shares of ILLUMINA, INC. (ILMN) at $162.41 ($11.41M total) on 2026-06-01.

Original reporting
SEC EDGAR · Meister Keith A.
Published Jun 1, 2026, 10:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ILMN
Neutral
medium confidence
Mentioned
$ILMN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

This disclosure updates the market on insider selling activity but does not provide new operational or financial information about Illumina.

02

Market read

Traders may monitor for follow-on insider activity, but the article alone is unlikely to drive a major repricing.

03

What to watch

The filing notes indirect ownership and no 10b5-1 plan; without context on tax/liquidity needs or prior sale patterns, interpreting intent is uncertain.

Relevance 6/10Novelty 3/10Timing: Filed today (2026-06-01) — potential intraday sentiment read-through from insider selling.

Background

SEC Form 4 reports insider transactions by directors/officers/10% owners; these are often used as sentiment/positioning signals rather than fundamental catalysts.

Company-level read

Ticker impact

$ILMNNeutralMedium confidence
Context

Illumina director Keith A. Meister sold 70,262 shares in an open-market transaction totaling about $11.41M, disclosed via SEC Form 4.

Expected impact

Low likelihood of a sustained price move solely from this disclosure; any impact is likely short-lived unless follow-on selling appears.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/guidance/M&A). It provides a datapoint on selling activity, but the article does not indicate a change in company outlook or a forced sale.

Market effects

Limited read-through to biotech/genomics tools sentiment; no sector-wide catalyst is described.

None indicated; US-listed single-name Form 4 disclosure.

None indicated; transaction is company-specific and not tied to global events.

Counterpoint

A director open-market sale may be routine diversification/plan-related and not a signal of deteriorating fundamentals, especially without a 10b5-1 plan detail.

Key entities

  • Illumina, Inc.

    US-listed genomics company subject of the insider transaction disclosure.

  • Keith A. Meister

    Director who sold 70,262 shares for ~$11.41M on 2026-06-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ILMNHighAI 8/10

Illumina Q2FY26 Results: Revenue up 9.5% to $1.16 billion

Illumina reported Q2 2026 revenue of $1.16B, up 9.5% YoY, driven by NovaSeq X demand and clinical consumables growth. Non-GAAP EPS rose 10% to $1.31. The company raised full-year guidance, projecting revenue of $4.60B-$4.64B and EPS of $5.30-$5.40. Management cited strong instrument placements and cost management despite rising expenses. Illumina repurchased 0.9M shares and holds $1.17B in cash. The stock has returned 13.26% annually over 20 years, outperforming the market by 3.84%.

$ILMNHighAI 8/10

Illumina Reports Q2 2026 Results: Full Earnings Call Transcript - Illumina (NASDAQ:ILMN)

Illumina (ILMN) reported Q2 2026 revenue growth of 9.5% YoY and EPS growth of 10%, driven by strong demand for NovaSeq X. The company raised its 2026 guidance, expecting full-year organic revenue growth over 5% and mid-teens growth in clinical consumables. Strategic initiatives include expanding multi-omics capabilities and strengthening the BioInsight platform. Management emphasized cost management and confidence in long-term targets.

$BELow

Three Stocks Are Joining the S&P 500. Will They Actually Improve VOO’s Returns?

Vanguard S&P 500 ETF (VOO) will add Bloom Energy (BE), Illumina (ILMN), and another company, while removing Molson Coors (TAP), The Trade Desk (TTD), and Builders FirstSource (BLDR). BE's product revenue surged 215% due to AI demand, and ILMN raised EPS guidance. The changes have minimal impact on VOO's returns, as the fund is heavily concentrated in megacap stocks.

$ILMNHigh

Illumina Stock Climbs As Analyst Upgrades Meet S&P 500 Boost

Illumina Inc. (ILMN) shares rose 7.15% on September 15, 2026, after UBS upgraded it to Buy with a $260 price target, and Argus raised its target to $235. The company's Q2 revenue was $1.16B, with EBITDA of $354M. Illumina is also being added to the S&P 500, effective September 21, 2026, which may drive further demand. The stock trades at a P/E ratio of 38 and P/S ratio of 6.9, reflecting its growth prospects. Analysts cite revenue reacceleration, margin expansion, and clinical demand as key driv